A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly partners with Sosei Group to develop, commercialize small molecules that modulate novel G protein-coupled receptor targets associated with diabetes, metabolic diseases; firms to use Sosei Heptares' StaR technology and drug design platform

Eli Lilly partners with biotech Nimbus Therapeutics to develop novel targeted therapies for metabolic diseases; Nimbus to use its computational drug discovery engine and Lily to assume development, global commercialization activities

Amgen opens new 245,000 square-foot, nine-story R&D facility in San Francisco, California, with staff of 650; new facility to focus on discovering cancer, inflammatory disease, cardiometabolic disorder therapies

Fitch upgrades Sanofi's outlook to positive from stable, reflecting its transition toward innovative pharmaceutical company and vaccine producer, away from cardio-metabolic leader with rare disease franchise, broad portfolio of legacy off-patent drugs

Abbott releasing 12 metabolic nutrition formulas previously on hold free of charge to patients; products were on hold following recall of some powdered infant formulas, with product manufacturing to resume at Sturgis, Michigan, plant pending FDA approval

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count